• 1
    James OFW, Day CP. Non-alcoholic steatohepatitis: another disease of affluence. Lancet 1999; 353:16341636.
  • 2
    Clark JM, Brancati FL, Diehl AME. Nonalcoholic fatty liver disease: the most common cause of abnormal liver enzymes in the U.S. population [Abstract]. Gastroenterology 2001; 120(Suppl A):65.
  • 3
    Caldwell SH, Oelsner DH, Lezzoni JC, Hessenheide EE, Battle EH, Driscoll CJ. Cryptogenic cirrhosis: clinical characterisation and risk factors for underlying disease. Hepatology 1999; 29:664669.
  • 4
    Bugianesi E, Leone N, Vanni E, Marchesini G, Brunello F, Crucci P, Musso A, et al. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 2002; 123:134140.
  • 5
    Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002; 346:12211231.
  • 6
    Pagano G, Pacini G, Musso G, Gambino R, Mecca F, Depetris N, Cassader M, et al. Non-alcoholic steatohepatitis, insulin resistance and metabolic syndrome: further evidence for an etiologic association. Hepatology 2002; 35:367372.
  • 7
    Cassader M, Gambino R, Musso G, Depetris N, Mecca F, Cavallo-Perin P, Pacini G, et al. Postprandial triglyceride-rich lipoprotein metabolism and insulin sensitivity in nonalcoholic steatohepatitis patients. Lipids 2001; 36:11171124.
  • 8
    Hu FB,van Dam RM, Liu S. Diet and risk of type II diabetes: the role of types of fat and carbohydrate. Diabetologia 2001; 44:805817.
  • 9
    Thomsen C, Rasmussen O, Lousen T, Holst JJ, Fenselau S, Schrezenmeir, Hermansen K. Differential effects of saturated and monounsaturated fatty acids on postprandial lipemia and incretin responses in healthy subjects. Am J Clin Nutr 1999; 69:11351143.
  • 10
    Mezey E. Dietary fat and alcoholic liver disease. Hepatology 1998; 28:901905.
  • 11
    Fernandez MI, Torres MI, Gil A, Rios A. Steatosis and collagen content in experimental liver cirrhosis are affected by dietary monounsaturated and polyunsaturated fatty acids. Scand J Gastroenterol 1997; 32:350356.
  • 12
    Angulo P, Lindor KD. Treatment of nonalcoholic fatty liver: present and emerging therapies. Semin Liver Dis 2001; 21:8188.
  • 13
    Diehl AM, Goodman Z, Ishak KG. Alcohol-like liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury. Gastroenterology 1988; 95:10561062.
  • 14
    Pisani P, Faggiano F, Krogh V, Palli D, Vineis P, Berrino F. Relative validity and reproducibility of a food frequency dietary questionnaire for use in the Italian EPIC centres. Int J Epidemiol 1997; 26:(Suppl 1):S152S160.
  • 15
    Sacerdote C, Fiorini L, Dalmasso M, Vineis P. Alimentazione e rischi di cancro. Indagine su un campione di 10054 volontari residenti nell'area torinese. Torino: AGAT, 2000.
  • 16
    Carnovale E, Marletta L. Tabella di composizione degli alimenti. Istituto Nazionale della Nutrizione. Milano: EDRA, 1997
  • 17
    Salvini S, Parpinel M, Gnagnarella P, Maisonneuve P, Turrini A. Banca Dati di Composizione degli Alimenti per Studi Epidemiologici in Italia. Istituto Europeo di Oncologia, 1988.
  • 18
    Matsuda M, DeFronzo R. Insulin sensitivity indices obtained from oral glucose tolerance testing. Comparison with the euglycemic insulin clamp. Diabetes Care 1999; 22:14621470.
  • 19
    Executive summary of the third report of the national cholesterol education program (NCEP) export panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult treatment panel III). JAMA 2001; 285:24862497.
  • 20
    Clarke SD. Nonalcoholic steatosis and steatohepatitis. I. Molecular mechanism for polyunsaturated fatty acid regulation of gene transcription. Am J Physiol Gastrointest Liver Physiol 2001; 281:G865G869.
  • 21
    Kliewer SA, Sundseth SS, Jones SA, Brown PJ, Wisely GB, Koble CS, Devachand P, et al. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ. Proc Natl Acad Sci U S A 1997; 94:43184323.
  • 22
    Jump DB, Clarke SD. Regulation of gene expression by dietary fat. Annu Rev Nutr 1999; 19:6390.
  • 23
    Loguercio C, De Girolamo V, De Sio I, Tuccillo C, Ascione A, Baldi F, Budillon G, et al. Non-alcoholic fatty liver disease in an area of southern Italy: main clinical, histological and pathophysiological aspects. J Hepatol 2001; 35:568574.
  • 24
    Lavine JE. Vitamin E treatment of nonalcoholic steatohepatitis in children: a pilot study. J Pediatr 2000; 136:734738.
  • 25
    Hasegawa T, Yoneda M, Nakamura K, Makino I, Terano A. Plasma transforming growth factor-β1 level and efficacy of α-tocopherol in patients with non-alcoholic steatohepatitis: a pilot study. Aliment Pharmacol Ther 2001; 15:16671672.
  • 26
    Cooper AD. Hepatic uptake of chylomicron renmants. J Lipid Res 1997; 38:21732192.
  • 27
    Sharrett AR, Heiss G, Chambless LE, Boerwinkle E, Coady SA, Folson AR, Patsch W. Metabolic and lifestyle determinants of postprandial lipemia differ from those of fasting triglycerides. The Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb Vasc Biol 2001; 21:275281.
  • 28
    Tholstrup T, Sandstrom B, Bysted A, Holmer G. Effect of 6 dietary fatty acids on the postprandial lipid profile, plasma fatty acids, lipoprotein lipasi, and cholesterol ester transfer activities in healthy young men. Am J Clin Nutr 2001; 73:198208.
  • 29
    Charlton M, Sreekumar R, Rasmussen D, Lindor K, Nair KS. Apolipoprotein synthesis in nonalcoholic steatohepatitis. Hepatology 2002; 35:898904.
  • 30
    Gleeson A, Anderton K, Owens D, Bennett A, Collins P, Johnson A, White D, et al. The role of microsomal triglyceride transfer protein and dietary cholesterol in chylomicron production in diabetes. Diabetologia 1999; 42:944948.
  • 31
    Bernard S, Toupet S, Persone I, Lapras V, Bonbon PJ, Berthezene F, Moulin P. Association between microsomal triglyceride transfer protein gene polymorphism and the biological features of liver steatosis in patients with type II diabetes. Diabetologia 2000; 43:995999.
  • 32
    Boden G. Perspectives in diabetes: role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 1997; 46:310.